Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein
Chan, S. H.; Tirole, L.; Kneller, D. W.; Kelley, T. M.; Dai, N.; Robb, G. B.
Show abstract
mRNA vaccines and therapeutics are highly effective and can be developed and manufactured with a relatively short lead time. Here we report an all-enzyme platform to generate capped synthetic RNA in a one-step process based on an RNA capping enzyme-T7 RNA polymerase fusion protein. Under standard in vitro transcription reaction conditions, the fusion protein, in conjunction with an RNA cap 2'-O-methyltransferase, can generate synthetic mRNA with up to 95% of Cap-1 incorporation, greatly simplifying mRNA manufacturing workflows.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification and in vitro characterization of UDP-GlcNAc-RNA cap-modifying and decapping enzymes 95%
- The Effect of Pseudoknot Base Pairing on Cotranscriptional Structural Switching of the Fluoride Riboswitch 95%
- PolyA tail segmentation improves the stability of the template DNA and increases the translatability of in vitro transcribed mRNA 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.